Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J Bejar
Downregulation of Sef, an Inhibitor of Receptor Tyrosine Kinase Signaling, Is Common to a Variety of Human Carcinomas
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
The Human Sef-A Isoform Utilizes Different Mechanisms to Regulate Receptor Tyrosine Kinase Signaling Pathways and Subsequent Cell Fate
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Insulin-Like Growth Factor-I Receptor Blockade by a Specific Tyrosine Kinase Inhibitor for Human Gastrointestinal Carcinomas
Molecular Cancer Therapeutics
Cancer Research
Oncology
The Pim-1 Protein Kinase Is an Important Regulator of MET Receptor Tyrosine Kinase Levels and Signaling
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Metastatic Adamantinoma Responds to Treatment With Receptor Tyrosine Kinase Inhibitor
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
A Phosphoproteomic Analysis of the ErbB2 Receptor Tyrosine Kinase Signaling Pathways
Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
The Selectivity of Receptor Tyrosine Kinase Signaling Is Controlled by a Secondary SH2 Domain Binding Site
Cell
Biochemistry
Genetics
Molecular Biology
Preclinical Overview of Sorafenib, a Multikinase Inhibitor That Targets Both Raf and VEGF and PDGF Receptor Tyrosine Kinase Signaling
Molecular Cancer Therapeutics
Cancer Research
Oncology
Inhibition of Angiogenesis by Erbstatin, an Inhibitor of Tyrosine Kinase.
Journal of Antibiotics
Drug Discovery
Pharmacology
